What is due today
Document requests, query context, eISF exchange, monitor commitments, duplicate Sponsor/CRO asks, source questions, and consent-version tasks stay in one site-owned queue.
Sites
PIs, coordinators, research nurses, and site managers need one clear queue for what is due, which study it belongs to, which protocol version applies, and whether the person assigned is allowed to act.
Coordinator queue
Show each coordinator what is due before the next visit: study, protocol version, consent state, source question, owner, and whether DOA and training allow action.
Document requests, query context, eISF exchange, monitor commitments, duplicate Sponsor/CRO asks, source questions, and consent-version tasks stay in one site-owned queue.
DOA, training currency, Site role, protocol version, procedure eligibility, and SSO context are visible before work begins.
Which study is this for? Which protocol version applies? Is this person delegated and trained to do the work?
PI accountability
PI accountability is not satisfied by a DOA log discovered at close-out. Delegation, source evidence, signature meaning, training currency, and monitor follow-up need to be visible during the trial.
Delegation changes, signature evidence mode, meaning, signer identity, and effective dates stay connected to the Site record.
Source evidence, consent-version context, eISF exchange, and monitor follow-up stay tied to the right subject, Site, and trial.
Who was delegated when the work happened? Which consent version was active? What evidence supports the Site response?
Sponsor and CRO work
Sponsors and CROs need evidence, but Sites need the work to arrive in a way that respects staffing, source systems, IRB cadence, and patient-care interruptions.
Site requests carry study, Site, artifact, owner, due date, protocol version, and source context instead of arriving as disconnected messages.
High-performing Sites can see cross-study obligations without losing Sponsor-specific permissions or trial boundaries.
Which requests are duplicates? Which work is patient-facing? Which evidence flows to the Sponsor, CRO, or eTMF?
First rollout
We will review the product path, system context, owners, evidence, and rollout approach that fit the trial work in front of you.